findmyKOL
Clinical trialNCT02024373CompletedPhase 2Interventional

Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma

SponsorOriental Neurosurgery Evidence-Based-Study TeamEnrollment200Chronic Subdural Hematoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Ning jian zhang, MD, PhD

    Tianjin Medical University General Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Beijing Tiantan Hospital

    Beijing, Beijing Municipality, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

  • Chinese Pla General Hospital

    Beijing, China

  • Peking Union Medical College Hospital

    Beijing, China

  • Cangzhou Centerl Hospital

    Cangzhou, China

  • Xiangya Hospital Central Southe University

    Changsha, China

  • Southwest Hospital

    Chongqing, China

  • West China Hospital

    Chongqing, China

  • the First Affiliated Hospital of Fujian Medical University

    Fuzhou, China

  • Nanfang Hospital

    Guangzhou, China

  • First Affiliated Hospital of Harbin Medical University

    Haerbing, China

  • Hainan General Hospital

    Haikou, China

  • 117 Hospital of People'S Liberation Army

    Hangzhou, China

  • the Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, China

  • Anhui Provincial Hospital

    Hefei, China

  • Inner Mongolia People'S Hospital

    Hohehot, China

  • Qilu Hospital of Shandong University

    Jinan, China

  • Linyi People'S Hospital

    Linyi, China

  • Jiangsu Province Hospital

    Nanjing, China

  • Ordos Central Hospital

    Ordos, China

  • Changzheng Hospital

    Shanghai, China

  • Huashan Hospital

    Shanghai, China

  • the Second Hospital of Hebei Medical University

    Shijiazhuang, China

  • the First Hospital of Shanxi Medical University

    Taiyuan, China

  • Tongji Hospital

    Wuhan, China

  • Tangdu Hospital

    Xi'an, China

  • Xijing Hospital

    Xi'an, China

  • Prince of Wales Hospital

    Xianggang, China

  • the Affiliated Hospital of Xuzhou Medical College

    Xuzhou, China

  • General Hospital of Ningxia Medical University

    Yinchuan, China

  • the First Affiliated Hospital of Zhengzhou University

    Zhengzhou, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2013
Primary completion
30 Apr 2016
Completion
30 Sept 2016
Last update posted
25 Oct 2016
Registered enrollment
200
Registry id
NCT02024373

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.